Concepedia

Author

Hanchuan Xu

Fujian Medical University

Also Known As

H. Xu, Han-Chuan Xu, Hanchuan Xu

27

Publications

220

Citations

8

H-Index

9

Concepts

All Affiliations

Fujian Medical UniversityFujian Provincial Cancer HospitalShanghai Jiao Tong UniversityNanchang UniversityJiangxi Provincial Cancer Hospital
HX

About

Hanchuan Xu is an author at Fujian Medical University specializing in radiology, medicine, and adaptive radiotherapy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Health Sciences

2

2

44

2

Medicine

2

2

44

3

Radiation Medicine

2

2

44

4

Adaptive Radiotherapy

2

2

44

5

Surgical Oncology

1

1

19

Hanchuan Xu

×

8

Publications

170

Citations

8

H-Index

YearCitations

Maintenance chemotherapy using S-1 following definitive chemoradiotherapy in patients with N3 nasopharyngeal carcinoma

Jingfeng Zong, Hanchuan Xu, Bijuan Chen,

Radiation Oncology

2019

33

<p>Stanniocalcin 2 (STC2) expression promotes post-radiation survival, migration and invasion of nasopharyngeal carcinoma cells</p>

Huocong He, Shuo Qie, Qiaojuan Guo,

Cancer Management and Research

2019

29

Identifying the optimal candidates for locoregional radiation therapy in patients with de novo metastatic nasopharyngeal carcinoma

Hanchuan Xu, Lihu Lu, Tianzhu Lu,

Head & Neck

2021

26

Modified reduced-volume intensity-modulated radiation therapy in non-metastatic nasopharyngeal carcinoma: A prospective observation series

Qiaojuan Guo, Yahan Zheng, Jinyong Lin,

Radiotherapy and Oncology

2021

25

Level Ib sparing intensity-modulated radiation therapy in selected nasopharyngeal carcinoma patients based on the International Guideline

Qiaojuan Guo, Nan Xiao, Hanchuan Xu,

Radiotherapy and Oncology

2021

19

Administration of oral maintenance chemotherapy for 1 year following definitive chemoradiotherapy may improve the survival of patients with stage N3 nasopharyngeal carcinoma

Jingfeng Zong, Yuhong Liu, Qiandong Liang,

Oral Oncology

2021

14

<p>Oral Maintenance Chemotherapy Using S-1/Capecitabine in Metastatic Nasopharyngeal Carcinoma Patients After Systemic Chemotherapy: A Single-Institution Experience</p>

Qiaojuan Guo, Mengwei Chen, Hanchuan Xu,

Cancer Management and Research

2020

12

Constructing an individualized surveillance framework for nasopharyngeal carcinoma based on a dynamic risk-adapted approach

Tianzhu Lu, Hanchuan Xu, Wanfang Huang,

Radiotherapy and Oncology

2023

12

Page 1